SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 110 filers reported holding SUTRO BIOPHARMA INC in Q3 2023. The put-call ratio across all filers is 1.10 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,617,373 | -25.4% | 3,347,946 | 0.0% | 0.31% | -27.9% |
| Q2 2023 | $15,567,949 | +0.6% | 3,347,946 | 0.0% | 0.43% | -23.2% |
| Q1 2023 | $15,467,511 | -42.8% | 3,347,946 | 0.0% | 0.56% | -50.5% |
| Q4 2022 | $27,051,404 | +41.4% | 3,347,946 | -2.9% | 1.14% | +44.6% |
| Q3 2022 | $19,136,000 | +6.5% | 3,447,946 | 0.0% | 0.79% | -9.0% |
| Q2 2022 | $17,964,000 | -36.6% | 3,447,946 | 0.0% | 0.87% | -23.5% |
| Q1 2022 | $28,342,000 | +105.9% | 3,447,946 | +272.7% | 1.13% | +126.8% |
| Q4 2021 | $13,766,000 | -11.9% | 925,148 | +11.9% | 0.50% | -17.9% |
| Q3 2021 | $15,619,000 | +1.6% | 826,825 | 0.0% | 0.61% | +5.7% |
| Q2 2021 | $15,371,000 | -18.3% | 826,825 | 0.0% | 0.58% | -18.4% |
| Q1 2021 | $18,819,000 | -53.2% | 826,825 | -55.4% | 0.71% | -55.4% |
| Q4 2020 | $40,254,000 | +29.7% | 1,854,162 | -39.9% | 1.58% | -6.3% |
| Q3 2020 | $31,026,000 | +68.8% | 3,087,195 | +30.3% | 1.69% | +49.2% |
| Q2 2020 | $18,379,000 | +278.9% | 2,368,392 | +398.1% | 1.13% | +150.7% |
| Q1 2020 | $4,850,000 | +27.7% | 475,482 | +37.7% | 0.45% | +56.9% |
| Q4 2019 | $3,797,000 | +21.3% | 345,196 | +0.3% | 0.29% | -12.5% |
| Q3 2019 | $3,129,000 | – | 344,196 | – | 0.33% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,824,542 | $39,611,000 | 19.08% |
| Samsara BioCapital, LLC | 1,675,579 | $36,377,000 | 3.66% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 185,000 | $4,016,000 | 2.33% |
| Affinity Asset Advisors, LLC | 200,000 | $4,342,000 | 2.30% |
| Altium Capital Management LP | 276,719 | $6,008,000 | 2.24% |
| FRAZIER MANAGEMENT LLC | 1,001,421 | $21,741,000 | 1.67% |
| BVF INC/IL | 1,854,162 | $40,254,000 | 1.58% |
| Asymmetry Capital Management, L.P. | 157,583 | $3,421,000 | 1.56% |
| Parkman Healthcare Partners LLC | 266,645 | $5,789,000 | 1.48% |
| AJU IB Investment Co., Ltd. | 175,000 | $3,799,000 | 1.44% |